1 Paper 2
1 Paper 2
1 Paper 2
Code: 1509
B.Sc. CARDIAC TECHNOLOGY
FIRST YEAR
Paper II – PATHOLOGY, MICROBIOLOGY AND PHARMACOLOGY
RELATED TO CARDIAC TECHNOLOGY
******
[LI 0216] FEBRUARY 2016 Sub. Code: 1509
B.Sc. CARDIAC TECHNOLOGY
(New Syllabus 2014-2015)
FIRST YEAR
Paper II – PATHOLOGY, MICROBIOLOGY AND PHARMACOLOGY
RELATED TO CARDIAC TECHNOLOGY
1. Antihypertensives drugs.
2. Protamine.
3. Explain the uses and adverse effects of proton pump inhibitors.
4. Hypertrophic Cardiomyopathy.
5. Etiology and clinical features of constrictive pericarditis.
6. Major criteria for Infective Endocarditis.
7. Atherosclerosis.
8. Rheumatic fever.
1. Systemic Hypertension.
2. Write about Warfarin.
3. Digoxin.
4. Name 3 cyanotic congenital heart diseases.
5. Takayasu Arteritis.
6. Pulmonary thromboembolism.
7. Aortic aneurysm.
8. Sinus node dysfunction.
9. Prevention of Deep vein Thrombosis.
10. Enumerate non modifiable coronary risk factors.
******
[LJ 0816] AUGUST 2016 Sub. Code: 1509
B.Sc. CARDIAC TECHNOLOGY
(New Syllabus 2014-2015)
FIRST YEAR
Paper II – PATHOLOGY, MICROBIOLOGY AND PHARMACOLOGY
RELATED TO CARDIAC TECHNOLOGY
******
[LK 0217] FEBRUARY 2017 Sub. Code: 1509
B.Sc. CARDIAC TECHNOLOGY
(New Syllabus 2014-2015)
FIRST YEAR
Paper II – PATHOLOGY, MICROBIOLOGY AND PHARMACOLOGY
RELATED TO CARDIAC TECHNOLOGY
1. Labetalol.
2. Ebstein anomaly.
3. Complications of Pulmonary Hypertension.
4. Thrombolytic drugs.
5. ACE inhibitors.
6. Sinus tachycardia.
7. Changes in ageing heart.
8. Ambulatory ECG monitoring.
9. Common organisms causing infective endocarditis.
10. Chagas disease.
******
[LL 0817] AUGUST 2017 Sub. Code: 1509
B.Sc. CARDIAC TECHNOLOGY
(New Syllabus 2014-2015)
FIRST YEAR
Paper II – PATHOLOGY, MICROBIOLOGY AND PHARMACOLOGY
RELATED TO CARDIAC TECHNOLOGY
1. Classify and mention the risk factors of hypertension. Briefly discuss about
role of kidney in regulation of blood pressure.
2. What are the conditions affecting the heart valve? Discuss in detail about
morphological changes in mitral valve in rheumatic heart disease.
3. What is aneurysm? Name two causes of aneurysm and describe the
morphology.
1. Coarctation of aorta.
2. Pulmonary embolism.
3. Angioplasty.
4. Causes of left sided heart failure.
5. Ventricular septal defect.
6. Classify calcium channel blockers.
7. Churg-Strauss syndrome.
8. Major risk factors of atherosclerosis.
9. Mention the infective and non-infective causes of pericarditis.
10. Thromboangitis obliterans.
******
[LM 0218] FEBRUARY 2018 Sub. Code: 1509
B.Sc. CARDIAC TECHNOLOGY
(New Syllabus 2014-2015)
FIRST YEAR
Paper II – PATHOLOGY, MICROBIOLOGY AND PHARMACOLOGY
RELATED TO CARDIAC TECHNOLOGY
1. Causes of pericarditis.
2. Mitral valve prolapse.
3. Cardinal anatomic changes of mitral valve in rheumatic heart disease.
4. Diagnostic criteria for infective endocarditis.
5. Complications of cardiac valve prostheses.
6. ACE inhibitors in hypertension.
7. Anti failure management.
8. Complications of myocardial infarction.
******
[LN 0818] AUGUST 2018 Sub. Code: 1509
B.Sc. CARDIAC TECHNOLOGY
(New Syllabus 2014-2015)
FIRST YEAR
Paper II – PATHOLOGY, MICROBIOLOGY AND PHARMACOLOGY
RELATED TO CARDIAC TECHNOLOGY
1. Describe the morphology of cardiac myxomas and name any other tumours
of heart.
2. Classify the anti-atherosclerotic drugs. Discuss the mechanism of action of statins.
3. Enumerate the causes of acquired heart valve diseases.
4. Pathophysiology of congenital acyanotic heart diseases.
5. Mention the disorders predisposing to Cor Pulmonale.
6. Causes and consequences of hypertrophic cardiomyopathy.
7. What are the causes of aortic dissection and describe the different types?
8. What are the predisposing factors of hypertension?
1. Mitral regurgitation.
2. Cardiac tamponade.
3. Wegner’s granulomatosis.
4. Causes of lymphedema.
5. Furosemide.
6. Atheromatous plaque.
7. Causes and effects of deep vein thrombosis.
8. Heart failure cells.
9. Complications of infective endocarditis.
10. Clopidogrel in the management of myocardial infarction.
******
[LO 0219] FEBRUARY 2019 Sub. Code: 1509
1. Loop diuretics.
2. Beta blockers.
3. Digoxin.
4. Constrictive pericarditis.
5. Types of angina pectoris.
6. Aortic dissection.
7. Deep vein thrombosis.
8. Cardiac rehabilitation.
******
[LP 0819] AUGUST 2019 Sub. Code: 1509
1. Labetolol.
2. Uses of Adrenaline.
3. Vasopressin analogues and their uses.
4. Glycoprotein 2b3a Antagonists.
5. Causes of heart failure.
6. What is Primary Pulmonary Hypertension?
7. Valvuloplasty.
8. Complications of Cardiac Valve Prosthesis.
9. Role of Renin in Hypertension.
10. Ebstein anomaly.
******
[LQ 0220] FEBRUARY 2020 Sub. Code: 1509
1. Fibrinolytics.
2. Angiotensin Converting Enzyme inhibitors.
3. Morphine.
4. Giant cell arteritis.
5. Corpulmonale.
6. Tetralogy of Fallot.
7. Pericardial effusion.
8. Hypertrophic cardiomyopathy.
1. Adenosine.
2. Mechanism of action of Diazepam.
3. Uses of Corticosteroids.
4. Dobutamine.
5. Cardiac tamponade.
6. Major criteria of Infective endocarditis.
7. Pseudoaneurysm.
8. Enumerate non modifiable coronary risk factors.
9. Angioplasty.
10. Ambulatory ECG monitoring.
******
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY
1. Tetrology of Fallot.
2. Giant cell arteritis.
3. Explain the uses and adverse effects of proton pump inhibitors.
4. Clopidogrel in ischemic heart disease.
5. Left atrial myxoma.
6. Types of angina pectoris.
7. Potassium sparing diuretics.
8. Statins.
1. Varicose veins.
2. Atheromatous plaque.
3. Angioplasty.
4. Ebstein anomaly.
5. Aschoff bodies.
6. Causes of left sided heart failure.
7. Enumerate non modifiable coronary risk factors.
8. Valvuloplasty.
9. Name five cardiotoxic drugs.
10. Ring abscess.
******
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY
1. Uses of Adrenaline.
2. Treatment of heparin toxicity.
3. Ambulatory ECG monitoring.
4. Renin-Angiotensin mechanism.
5. Churg-Strauss syndrome.
6. Changes in ageing heart.
7. X-ray chest and Echo findings in aortic regurgitation.
8. Acute coronary syndrome.
9. Enumerate non modifiable coronary risk factors.
10. Patent Ductus Arterisous.
****